# Gerresheimer and Portal Instruments partner on needle-free drug delivery

Gerresheimer AG invested in Portal Instruments to co-develop a needle-free drug delivery platform for biologics and biosimilars, aiming to improve patient experience and expand their product portfolios.

- Type: Partnership
- Announced: 2022-05-09
- Status: announced
- Products: needle-free drug delivery platform, biologics, biosimilars
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Gerresheimer](https://endata.com/companies/1928.md)
- [Portal Instruments](https://endata.com/companies/62759.md) (partner)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/gerresheimer-and-portal-enter-strategic-partnership-to-treat-chronically-ill-patients-with-innovative-needle-free-drug-delivery-solution-301542290.html), 2022-05-09: "Together, the partners aim at transforming the administration of injectable medicines and improving the patient's experience, especially for those with chronic diseases."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.